Abstract:Objective To evaluate the prevalence and the predictors of clopidogrel therapy after DES implantation,and to determine the impact of discontinuation of clopidogrel therapy on the occurrence of late stent thrombosis(ST)and very late stent thrombosis.Methods Between July 2003 and June 2005,2 930 consecutive patients treated with PCI and DES implantation in Anzhen hospital were involved in the study,and among them,13 patients died within 3 dys after PCI.A total of 2 704 patients out of the 2 917 patients were followed up successfully for at least 2 years,or mortality.All of the clinical,angiographic and intervention treatment character were recorded.ST was adjudicated by the definition of ARC Dublin.Patients were grouped by the duration of clopidogrel therapy to 4 groups(group 1,3 months;group 2,3-6 months;group 3,6-12 months;group 4,12 months).The duration of clopidogrel therapy and the predictors of the premature discontinuation of clopidogrel were evaluated,and the rate of late ST(1 month to 12 months)and very late ST(after 12 months)in the 4 groups were analysised.Results There were 82(3.0%)patients in group 1,333(12.3%)patients in group 2,1 590(58.8%)patients in group 3,and 699(25.9%)patients in group 4.In contrast with group 4,the mean level of total cholesterol were higher,mean LVEF value were lower,more patients were diabetes,less patients were STEMI,and the mean number of DES implantation was less in group 1-3.In group 1 and group 2,most of the discontinuation of clopidogrel therapy(95.1%,85.9% respectively)were directed by patients themselves;and in group 3,71.1% of the patients discortinued clopidogrel therapy on the doctor's order.There was no significant differences among the 3 groups on discontinuation of clopidogrel for bleeding or other operations.By Cox regression,diabetes(OR=1.542,95% CI=1.184-2.008,P=0.001)and number and DES implantation(OR=0.790,95% CI=0.709-0.880,P0.001)were found to be the independent predictors of discontinuation of clopidogrel.There were significant differences among the 4 groups on the rate of late ST and very late ST(6.1% vs 1.2% vs 0.8% vs 0%,P0.001).The late ST and very late ST rate of group 3 were also significantly higher than that of group 4(0.8% vs 0%,P=0.013).Conclusion In practice,approaching 75% of patients continue clopidogrel therapy no more than 12 months after DES implantation.Diabetes and number of DES implanted are the risk factors of prematurely discontinuation of clopidogrel therapy.The patients who premature discontinue clopidogrel therapy are prone to suffer from ST.

Risk Factors Analysis for Early Coronary Stent Thrombosis after Drug Eluting Stent Implantation

Predictors of in-stent stenosis and occlusion after endovascular treatment of intracranial vascular disease with the Willis covered stent.

[Long-Term Outcomes and Risk Factors of Ostial/shaft Lesions in Unprotected Left Main Coronary Artery after Percutaneous Coronary Intervention].

Analysis of Risk Factors for Early Stent Thrombosis in the Chinese Population: A Multicenter Restrospective Study.

Risk Factors Associated With Outcomes of Non-cardioembolic Ischemic Stroke In Patients Stratified By Essen Stroke Risk Score

Clinical Outcomes and Risk Factors of Coronary Artery Aneurysms after Successful Percutaneous Coronary Intervention and Drug-Eluting Stent Implantation for Chronic Total Occlusions

Security Analysis of Implanting Drug-Eluting Stents for Unprotected Left Main Coronary Artery Disease Patients with Chronic Kidney Disease

Long-term Prognosis of Drug Eluting Stents Implantation in Elderly Patients with Unprotected Left Main Coronary Artery Disease

Incidence and Predictors of Definite Stent Thrombosis after Coronary Stent Implantation.

Drug-Eluting Stent and Late Stent Thrombosis

Investigation Into the Risk Factors Related to In-stent Restenosis in Elderly Patients With Coronary Heart Disease and Type 2 Diabetes Within 2 Years After the First Drug-Eluting Stent Implantation

Prevalence, Predictors, and Impact of Discontinuation of Clopidogrel Therapy after Drug-Eluting Stent Implantation

Drug Eluting Stents in Renal Functional Insufficiency Patients and Its Influence on Stent Thrombosis.

Patient-Related Factors Predicting Stent Thrombosis in Percutaneous Coronary Interventions

High platelet reactivity strongly predicts early stent thrombosis in patients with drug-eluting stent implantation

Markers of coagulation and early coronary stent thrombosis

Prognosis of Patients with Acute ST-elevation Myocardial Infarction Due to Drug-Eluting Stent Thrombosis

Risk factors for in-stent restenosis after coronary stent implantation in patients with coronary artery disease: A retrospective observational study

Clinical Characteristics of Early and Late Drug-Eluting Stent In-Stent Restenosis and Mid-Term Prognosis after Repeated Percutaneous Coronary Intervention.

Factors associated with early, late, and very late stent thrombosis among patients with acute coronary syndrome undergoing coronary stent placement: analysis from the ATLAS ACS 2-TIMI 51 trial

Can "hybrid Stent Implantation" Improve Long-Term Safety Without Adversely Affecting Efficacy when Treating Multilesion Coronary Artery Disease in the Drug-Eluting Stent Era?